Significant clinical impact of recurrentBRCA1andBRCA2mutations in Mexico-Reference-Cited by-同舟云学术

Significant clinical impact of recurrentBRCA1andBRCA2mutations in Mexico

Published:2014-09-18 Issue:3 Volume:121 Page:372-378
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Villarreal-Garza Cynthia¹²,Alvarez-Gómez Rosa María³,Pérez-Plasencia Carlos⁴,Herrera Luis A.¹,Herzog Josef⁵,Castillo Danielle⁵,Mohar Alejandro¹,Castro Clementina¹,Gallardo Lenny N.¹,Gallardo Dolores⁶,Santibáñez Miguel¹,Blazer Kathleen R.⁵,Weitzel Jeffrey N.⁵

Affiliation:

1. Unit of Biomedical Cancer Research; National Cancer Institute-Institute for Biomedical Research, National Autonomous University of Mexico; Mexico Federal District Mexico

2. Technological Breast Cancer Center of Monterrey; Monterrey Nuevo Leon Mexico

3. Basic Research Branch, National Cancer Institute; Mexico Federal District Mexico

4. Oncogenomics Laboratory; National Cancer Institute; Mexico Federal District Mexico

5. Division of Clinical Cancer Genetics; City of Hope; Duarte California

6. Department of Medical Oncology; National Cancer Institute; Mexico Federal District Mexico

Funder

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.29058/fullpdf

Reference43 articles.

1. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario;Risch;Canada J Natl Cancer Inst,2006

2. Genetics, genomics and cancer risk assessment: state of the art and future directions in the era of personalized medicine;Weitzel;CA Cancer J Clin,2011

3. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families;Ford;Am J Hum Genet,1998

4. First breast cancer mammography screening program in Mexico: initial results 2005-2006;Rodriguez-Cuevas;Breast J,2009

5. Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity;Lara-Medina;Cancer,2011

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Molecular Characterization of the Allelic Expression of the BRCA1 Founder Δ9–12 Pathogenic Variant and Its Potential Clinical Relevance in Hereditary Cancer;International Journal of Molecular Sciences;2024-06-20

2. Germline mutations of breast cancer susceptibility genes through expanded genetic analysis in unselected Colombian patients;Human Genomics;2024-06-18

3. Genomic ancestry and cancer among Latin Americans;Clinical and Translational Oncology;2024-04-06

4. Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru;Frontiers in Oncology;2023-08-17

5. El consentimiento informado en cáncer hereditario;Gaceta Mexicana de Oncolog�a;2023-02-15